Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

pharma companies too started foraying into the segment thereby offering third-party services in drug manufacturing. Now based on an analysis by EY-Parthenon, there are three major CDMO archetypes ...

Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...

Insurance companies in Mumbai anticipate a 15-20% hike in third-party motor insurance premiums from April 1 due to increasing claims and stagnant rates. With TP award inflation nearly at 12% annually ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Jeddah – United Pharmacies Group has announced the signing of its first strategic agreement for the manufacturing of private-label pharmaceutical and therapeutic products in partnership with Avalon ...

As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...

M&A is an integral part of the lifecycle of pharma companies and a ... teams are comprised of in-house or third-party experts from independent companies such as NSF, who can quickly identify ...